These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 15871553
1. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity. Purnell JQ, Weyer C. Treat Endocrinol; 2003; 2(1):33-47. PubMed ID: 15871553 [Abstract] [Full Text] [Related]
2. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus. Hermansen K, Mortensen LS. Drug Saf; 2007; 30(12):1127-42. PubMed ID: 18035865 [Abstract] [Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ, Bailey CJ. Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [Abstract] [Full Text] [Related]
4. Novel pharmacologic agents for type 2 diabetes. Uwaifo GI, Ratner RE. Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927 [Abstract] [Full Text] [Related]
5. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus. Baron AD, Kim D, Weyer C. Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297 [Abstract] [Full Text] [Related]
6. New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues). Dharmalingam M, Kumar P. J Assoc Physicians India; 2001 Jan 25; 49 Spec No():46-9. PubMed ID: 11235605 [No Abstract] [Full Text] [Related]
7. The use of insulin secretagogues in the treatment of type 2 diabetes. Luna B, Hughes AT, Feinglos MN. Prim Care; 1999 Dec 25; 26(4):895-915. PubMed ID: 10523467 [Abstract] [Full Text] [Related]
8. Oral antidiabetic agents in type 2 diabetes. Levetan C. Curr Med Res Opin; 2007 Apr 25; 23(4):945-52. PubMed ID: 17407651 [Abstract] [Full Text] [Related]
9. Are you up-to-date on diabetes medications? Scemons D. Nursing; 2007 Jul 25; 37(7):45-9; quiz 49-50. PubMed ID: 17603373 [Abstract] [Full Text] [Related]
10. New treatments for patients with type 2 diabetes mellitus. Wolffenbuttel BH, Graal MB. Postgrad Med J; 1996 Nov 25; 72(853):657-62. PubMed ID: 8944206 [Abstract] [Full Text] [Related]
11. Complications of diabetes therapy. Corathers SD, Peavie S, Salehi M. Endocrinol Metab Clin North Am; 2013 Dec 25; 42(4):947-70. PubMed ID: 24286957 [Abstract] [Full Text] [Related]
12. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Weyer C, Maggs DG, Young AA, Kolterman OG. Curr Pharm Des; 2001 Sep 25; 7(14):1353-73. PubMed ID: 11472273 [Abstract] [Full Text] [Related]
14. Treatments and devices for future diabetes management. Capaldi B. Nurs Times; 2001 Sep 25; 101(18):30-2. PubMed ID: 15892503 [Abstract] [Full Text] [Related]
15. New drugs for type 2 diabetes mellitus: what is their place in therapy? Krentz AJ, Patel MB, Bailey CJ. Drugs; 2008 Sep 25; 68(15):2131-62. PubMed ID: 18840004 [Abstract] [Full Text] [Related]
17. The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus. Munir KM, Davis SN. Expert Opin Pharmacother; 2015 Jun 25; 16(15):2331-41. PubMed ID: 26340427 [Abstract] [Full Text] [Related]
18. Diabetes medications and body weight. Mitri J, Hamdy O. Expert Opin Drug Saf; 2009 Sep 25; 8(5):573-84. PubMed ID: 19538102 [Abstract] [Full Text] [Related]
19. New potential adjuncts to treatment of children with type 1 diabetes mellitus. Raman VS, Heptulla RA. Pediatr Res; 2009 Apr 25; 65(4):370-4. PubMed ID: 19092720 [Abstract] [Full Text] [Related]
20. Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis. Maggs D, Shen L, Strobel S, Brown D, Kolterman O, Weyer C. Metabolism; 2003 Dec 25; 52(12):1638-42. PubMed ID: 14669170 [Abstract] [Full Text] [Related] Page: [Next] [New Search]